Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT01086293
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older
* Newly prescribed Saxagliptin or an Oral Antidiabetic Drug (OAD) in a class other than Dipeptidyl peptidase IV (DPP4) inhibitors
* Enrolled in the respective database for at least 180 days prior to the first prescription of new OAD
* Have at least one diagnostic code for a type 2 diabetes-related condition
Exclusion Criteria:
* Patients identified with a diagnostic code for acute liver failure within the 180-day baseline period
* Patients with DPP4 inhibitor exposure during the baseline period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01086293
Study Brief:
Protocol Section:
NCT01086293